Join to access to all OVN content. Join for Free
A Trip Around the MSL Insights Cycle
MSL insights insight cycle competitive intelligence training MSLs audience understanding

A Trip Around the MSL Insights Cycle


Share This Article


Summary

In this episode, Patrina Pellett and Richard Swank join Tom Caravela to explore the intricacies of the MSL insight cycle. They delve into the growth and insights course, highlighting common mistakes and the importance of training MSLs on inputting insights. The discussion covers the stages of the insight cycle, with a focus on competitive intelligence and the gathering stage. Patrina and Richard emphasize the significance of understanding your audience and effective mechanisms for sharing insights. The episode wraps up by debunking common myths about insights and includes a call to action for listeners.

In this week’s episode, Patrina Pellett and Richard Swank  (both from MSL Growth) join me to take a trip around the MSL Insights Cycle.

Click for Source
MSL insights, insight cycle, competitive intelligence, training MSLs, audience understanding

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Insight about INSIGHTS, and how they can help your MSL career!
Partner Avatar MSL Talk: Tom Caravela, Joe Liberman

Insight about INSIGHTS, and how they can help your MSL career!

Podcast
How to maximize KOL engagement and MSL insights gathering at your next virtual congress with Patrina Pellet
Partner Avatar MSL Talk: Tom Caravela, Patrina Pellet

How to maximize KOL engagement and MSL insights gathering at your next virtual congress with Patrina Pellet

Article
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
OVN Avatar S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale

Article
Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois

Sponsorship of oncology clinical trials in the United States according to age of eligibility

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Article
Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?
OVN Avatar Karen Geary

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

Explore OVN